Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T22:35:23.605Z Has data issue: false hasContentIssue false
  • English
  • Français

Bioavailability of angiotensin I converting enzyme inhibitory peptides

Published online by Cambridge University Press:  09 March 2007

Vanessa Vermeirssen ,
John Van Camp  and
Willy Verstraete
Vanessa Vermeirssen
Affiliation:
Laboratory for Microbial Ecology and Technology and Nutrition, Ghent University, Faculty of Agriculture and Applied Biological Sciences, Ghent, Belgium Department of Food Technology and Nutrition, Ghent University, Faculty of Agriculture and Applied Biological Sciences, GhentBelgium
John Van Camp
Affiliation:
Department of Food Technology and Nutrition, Ghent University, Faculty of Agriculture and Applied Biological Sciences, GhentBelgium
Willy Verstraete*
Affiliation:
Laboratory for Microbial Ecology and Technology and Nutrition, Ghent University, Faculty of Agriculture and Applied Biological Sciences, Ghent, Belgium
*
*Corresponding author: fax + 32 92 64 62 48, Email willy.verstrete@UGent.be
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Hypertension or high blood pressure is a significant health problem worldwide. Bioactive peptides that inhibit angiotensin I converting enzyme (ACE) in the cardiovascular system can contribute to the prevention and treatment of hypertension. These ACE inhibitory peptides are derived from many food proteins, especially milk proteins. An ACE inhibitory activity in vitro does not always imply an antihypertensive effect in vivo. Even if it does, it is very difficult to establish a direct relationship between in vitro and in vivo activity. This is mainly due to the bioavailability of the ACE inhibitory peptides after oral administration and the fact that peptides may influence blood pressure by mechanisms other than ACE inhibition. To exert an antihypertensive effect after oral ingestion, ACE inhibitory peptides have to reach the cardiovascular system in an active form. Therefore, they need to remain active during digestion by human proteases and be transported through the intestinal wall into the blood. The bioavailability of some ACE inhibitory peptides has been studied. It is also known that (hydroxy)proline-containing peptides are generally resistant to degradation by digestive enzymes. Peptides can be absorbed intact through the intestine by paracellular and transcellular routes, but the potency of the bioactivity after absorption is inversely correlated to chain length. In addition, some strategies are proposed to increase the bioavailability of ACE inhibitory peptides. Further research into the bioavailability of ACE inhibitory peptides will lead to the development of more effective ACE inhibitory peptides and foods.

Keywords

Bioactive peptidesHypertensionGastrointestinal digestionIntestinal transport
Type
Review article
Information
British Journal of Nutrition , Volume 92 , Issue 3 , September 2004 , pp. 357 - 366
Copyright
Copyright © The Nutrition Society 2004

References

Clare, DA & Swaisgood, HEBioactive milk peptides: a prospectus J Dairy Sci. (2000) 83, 1187–1195CrossRefGoogle ScholarPubMed
Cushman, DW & Cheung, HSSpectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung Biochem Pharmacol (1971) 20 1637–1648CrossRefGoogle ScholarPubMed
Cushman, DW&Ondetti, MADesign of angiotensin converting enzyme inhibitors Nat Med (1999) 5 1110–1112CrossRefGoogle ScholarPubMed
Diplock, AT, Aggett, PJ, Ashwell, M,Bornet, F, Fern, EB&Roberfroid, MBScientific concepts of functional foods in Europe: consensus document Br J Nutr (1999) 81 S1–S27Google Scholar
Dooley, CT&Houghten, RANew opioid peptides, peptidomimetics, and heterocyclic compounds from combinatorial libraries Biopolymers (1999) 51 379–3903.0.CO;2-E>CrossRefGoogle ScholarPubMed
Drucker, DJ, Shi, Q, Crivici, A, Sumner Smith, M, Tavares, W, Hill, M, DeForest, L, Cooper, S&Brubaker, PLRegulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV Nat Biotechnol (1997) 15 673–677CrossRefGoogle ScholarPubMed
Duprez, D, Van Helshoecht, P, Van den Eynde, W&Leeman, MPrevalence of hypertension in the adult population of Belgium: report of a worksite study, Attention Hypertension J Hum Hypertens (2002) 16 47–52CrossRefGoogle ScholarPubMed
Dziuba, J, Minkiewicz, P&Nalecz, DBiologically active peptides from plant and animal proteins Pol J Food Nutr Sci (1999) 8 3–16Google Scholar
Elbl, G&Wagner, HA new method for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE), using the chromophore- and fluorophore-labelled substrate, dansyltriglycine Planta Med (1991) 57 137–141CrossRefGoogle ScholarPubMed
Eriksson, U, Danilczyk, U&Penninger, JMJust the beginning: novel functions for angiotensin-converting enzymes Curr Biol (2002) 12 745–752CrossRefGoogle ScholarPubMed
FitzGerald, RJ&Meisel, HMilk protein-derived peptide inhibitors of angiotensin-I- converting enzyme Br J Nutr (2000) 84 S33–S37CrossRefGoogle ScholarPubMed
Fujita, H, Usui, H, Kurahashi, K & Yoshikawa, MIsolation and characterization of ovokinin, a bradykinin B-1 agonist peptide derived from ovalbumin. Peptides (1995) 16, 785–790.CrossRefGoogle Scholar
Fujita, H, Yokoyama, K & Yoshikawa, MClassification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci (2000) 65, 564–569.Google Scholar
Fujita, H & Yoshikawa, MLKPNM: a prodrug-type ACE inhibitory peptide derived from fish protein. Immunopharmacology (1999) 44, 123–127.CrossRefGoogle ScholarPubMed
Furushiro, M, Hashimoto, S, Hamura, M & Yokokura, TMechanism for the antihypertensive effect of a polysaccharide–glycopeptide complex from Lactobacillus casei in spontaneously hypertensive rats (SHR). Biosci Biotechnol Biochem (1993) 57, 978–981.CrossRefGoogle ScholarPubMed
Furushiro, M, Sawada, H, Hirai, K, Motoike, M, Sansawa, H, Kobayashi, S, Watanuki, M & Yokokura, TBlood-pressure-lowering effect of extract from Lactobacillus casei in spontaneously hypertensive rats (SHR). Agric Biol Chem (1990) 54, 2193–2198.Google Scholar
Ganapathy, V & Leibach, FHProtein digestion and assimilation. In Textbook of Gastroenterology, pp. 456–467 [Yamada, T, editor]. Philadelphia, PA: Lippincott Williams & Wilkins. (1999)Google Scholar
Ganong, WF Section V. Gastrointestinal function. In Review of Medical Physiology, pp. 437–481. Stamford, CT: Appleton & Lange. (1997)Google Scholar
Gardner, MLGIntestinal assimilation of intact peptides and proteins from the diet – a neglected field?. Biol Rev (1984) 59, 289–331.CrossRefGoogle Scholar
Gardner, MLGGastrointestinal absorption of intact proteins. Annu Rev Nutr (1988) 8, 329–350.CrossRefGoogle ScholarPubMed
Gardner, MLGTransmucosal passage of intact peptides. In Peptides in Mammalian Metabolism. Tissue Utilization and Clinical Targeting [Grimble, GK & Backwell, FRC, editor]. London: Portland Press Ltd. (1998)Google Scholar
Grimble, GKMechanisms of peptide and amino acid transport and their regulation. In Proteins, Peptides and Amino Acids in Enteral Nutrition, pp. 63–88. [Fürst, P & Young, V, editor]. Basel: Nestec Ltd. (2000)Google ScholarPubMed
Harsha, DW, Lin, PH, Obarzanek, E, Karanja, N, Moore, T & Caballero, BDietary approaches to stop hypertension: a summary of study results. J Am Diet Assoc (1999) 99, S35–S39.CrossRefGoogle ScholarPubMed
Hata, Y, Yamamoto, M, Ohni, M, Nakajima, K, Nakamura, Y & Takano, TA placebo controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr (1996) 64, 767–771.CrossRefGoogle ScholarPubMed
Hermansen, KDiet, blood pressure and hypertension. Br J Nutr (2000) 83, Suppl. 1, S113–S119.CrossRefGoogle ScholarPubMed
Holmquist, B, Bünning, P & Riordan, JFA continuous spectrophotometric assay for the angiotensin converting enzyme. Anal Biochem (1979) 95, 540–548.CrossRefGoogle ScholarPubMed
Itakura, H, Ikemoto, S, Terada, S & Kondo, KThe effect of sour milk on blood pressure in untreated hypertensive and normotensive subjects. J Jpn Soc Clin Nutr (2001) 23, 26–31.Google Scholar
Karaki, H, Doi, K, Sugino, S, Uchiwa, H, Sugai, R, Murakam, U & Takemoto, SAntihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comp Biochem Physiol (1990) 96, 367–371.Google ScholarPubMed
Korhonen, H & Pihlanto, AFood-derived bioactive peptides – opportunities for designing future foods. Curr Pharm Des (2003) 9, 1297–1308.CrossRefGoogle ScholarPubMed
Krüger, C, Hu, Y, Pan, Q, et al.. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol (2002) 20, 702–706.CrossRefGoogle ScholarPubMed
Maeno, M, Yamamoto, N & Takano, TIdentification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci (1996) 79, 1316–1321.CrossRefGoogle ScholarPubMed
Maes, W, Van Camp, J, Vermeirssen, V, Hemeryck, M, Ketelslegers, JM, Schrezenmeir, J, Van Oostveldt, P & Huyghebaert, AInfluence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regul Pept (2004) 118, 105–109.CrossRefGoogle ScholarPubMed
Maruyama, S, Mitachi, H, Tanaka, H, Tomizuka, N & Suzuki, HStudies on the active site and antihypertensive activity of angiotensin I-converting enzyme inhibitors derived from casein. Agric Biol Chem (1987) 51, 1581–1586.Google Scholar
Masuda, O, Nakamura, Y & Takano, TAntihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr (1996) 126, 3063–3068.CrossRefGoogle ScholarPubMed
Matoba, N, Usui, H, Fujita, H & Yoshikawa, MA novel anti-hypertensive peptide derived from ovalbumin induces nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS Lett (1999) 452, 181–184.CrossRefGoogle Scholar
Matoba, N, Yamada, Y, Usui, H, Nakagiri, R & Yoshikawa, MDesigning potent derivatives of ovokinin(2–7), an anti-hypertensive peptide derived from ovalbumin. Biosci Biotechnol Biochem (2001) 65, 736–739.CrossRefGoogle ScholarPubMed
Matsui, T, Li, CH & Osajima, YPreparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. J Pept Sci (1999) 5, 289–297.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Matsui, T, Li, CH, Tanaka, T, Maki, T, Osajima, Y & Matsumoto, KDepressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biol Pharm Bull (2000) 23, 427–431.CrossRefGoogle Scholar
Matsui, T, Tamaya, K, Seki, E, Osajima, K, Matsumoto, K & Kawasaki, TAbsorption of Val-Tyr with in vitro angiotensin I-converting enzyme inhibitory activity into the circulating blood system of mild hypertensive subjects. Biol Pharm Bull (2002 a) 25, 1228–1230.CrossRefGoogle ScholarPubMed
Matsui, T, Tamaya, K, Seki, E, Osajima, K, Matsumoto, K & Kawasaki, TVal-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system. Clin Exp Pharmacol Physiol (2002 b) 29, 204–208.CrossRefGoogle ScholarPubMed
Mayo, KHRecent advances in the design and construction of synthetic peptides: for the love of basics or just for the technology of it. Trends Biotechnol (2000) 18, 212–217.CrossRefGoogle ScholarPubMed
Meisel, HBiochemical properties of bioactive peptides derived from milk proteins: potential nutraceuticals for food and pharmaceutical applications. Livest Prod Sci (1997 a) 50, 125–138.CrossRefGoogle Scholar
Meisel, HBiochemical properties of regulatory peptides derived from milk proteins. Biopolymers (1997 b) 43, 119–128.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Meisel, HOverview on milk protein-derived peptides. Int Dairy J (1998) 8, 363–373.CrossRefGoogle Scholar
Meisel, H & Bockelmann, WBioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie Van Leeuwenhoek (1999) 76, 207–215.CrossRefGoogle ScholarPubMed
Meisel, H & Frister, HChemical characterization of bioactive peptides from in vivo digests of casein. J Dairy Res (1989) 56, 343–349.CrossRefGoogle ScholarPubMed
Morris, MC, Depollier, J, Mery, J, Heitz, F & Divita, GA peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol (2001) 19, 1173CrossRefGoogle ScholarPubMed
Moskowitz, DWIs angiotensin I-converting enzyme a "master" disease gene?. Diabetes Technol Ther (2002) 4, 683–711.CrossRefGoogle ScholarPubMed
Moskowitz, DWIs 'somatic' angiotensin-I-converting enzyme a mechanosensor?. Diabetes Technol Ther (2003) 4, 841–858.CrossRefGoogle Scholar
Nakajima, K, Hata, Y, Osono, Y, Hamura, M, Kobayashi, S & Watanuki, MAntihypertensive effect of extracts of Lactobacillus casei in patients with hypertension. J Clin Biochem Nutr (1995) 18, 181–187.CrossRefGoogle Scholar
Nakamura, Y, Yamamoto, N, Sakai, K, Okubo, A, Yamazaki, S & Takano, TPurification and characterization of angiotensin I-converting enzyme inhibitors from a sour milk. J Dairy Sci (1995) 78, 777–783.CrossRefGoogle ScholarPubMed
Nurminen, ML, Sipola, M, Kaarto, H, Pihlanto-Leppala, A, Piilola, K, Korpela, R, Tossavainen, O, Korhonen, H & Vapaatalo, Hα-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci (2000) 66, 1535–1543.CrossRefGoogle ScholarPubMed
Oh, KS, Park, YS & Sung, HCExpression and purification of an ACE inhibitory peptide multimer from synthetic DNA in Escherichia coli. J Microbiol Biotechnol (2002) 12, 59–64.Google Scholar
Okitsu, M, Morita, A, Kakitani, M, Okada, M & Yokogoshi, HInhibition of the endothelin-converting enzyme by pepsin digests of food proteins. Biosci Biotechnol Biochem (1995) 59, 325–326.CrossRefGoogle ScholarPubMed
Pappenheimer, JR & Volpp, KTransmucosal impedance of small intestine – correlation with transport of sugars and amino acids. Am J Physiol (1992) 263, C480–C493.CrossRefGoogle ScholarPubMed
Pihlanto-Leppälä, ABioactive peptides derived from bovine whey proteins: opioid and ACE inhibitory peptides. Trends Food Sci Technol (2001) 11, 347–356.CrossRefGoogle Scholar
Pins, JJ, Keenan, JMThe antihypertensive effects of a hydrolyzed whey protein isolate supplement (BioZate 1). Cardiovasc Drugs Ther (2002) 16, Suppl. 1, 68.Google Scholar
Riordan, JFAngiotensin-I-converting enzyme and its relatives. Genome Biol (2003) 4, 225.CrossRefGoogle ScholarPubMed
Roberts, PR, Burney, JD, Black, KW & Zaloga, GPEffect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion (1999) 60, 332–337.CrossRefGoogle ScholarPubMed
Rubio, LA & Seiquer, ITransport of amino acids from in vitro digested legume proteins or casein in Caco-2 cell cultures. J Agric Food Chem (2002) 50, 5202–5206.CrossRefGoogle ScholarPubMed
Saito, T, Nakamura, T, Kitazawa, H, Kawai, Y & Itoh, TIsolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. J Dairy Sci (2000) 83, 1434–1440.CrossRefGoogle ScholarPubMed
Satake, M, Enjoh, M, Nakamura, Y, Takano, T, Kawamura, Y, Arai, S & Shimizu, MTransepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem (2002) 66, 378–384.CrossRefGoogle ScholarPubMed
Seppo, L, Jauhiainen, T, Poussa, T & Korpela, RA fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr (2003) 77, 326–330.CrossRefGoogle Scholar
Shimizu, MModulation of intestinal functions by food substances. Nahrung (1999) 43, 154–158.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Shimizu, M, Tsunogai, M & Arai, STransepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides (1997) 18, 681–687.CrossRefGoogle ScholarPubMed
Sipola, M, Finckenberg, P, Korpela, R, Vapaatalo, H & Nurminen, MLEffect of long-term intake of milk products on blood pressure in hypertensive rats. J Dairy Res (2002) 69, 103–111.CrossRefGoogle ScholarPubMed
Stamler, J, Elliott, P, Kesteloot, H, Nichols, R, Claeys, G, Dyer, AR & Stamler, RInverse relation of dietary protein markers with blood pressure. Findings for 10 020 men and women in the INTERSALT study. INTERSALT Cooperative Research Group: INTERnational study of SALT and blood pressure. Circulation (1996) 94, 1629–1634.CrossRefGoogle Scholar
Steidler, LIn situ delivery of cytokines by genetically engineered Lactococcus lactis. Antonie Van Leeuwenhoek (2002) 82, 323–331.CrossRefGoogle ScholarPubMed
Suetsuna, KIsolation and characterization of angiotensin I-converting enzyme inhibitor dipeptides derived from Allium sativum L (garlic). J Nutr Biochem (1998) 9, 415–419.CrossRefGoogle Scholar
Svedberg, J, de Haas, J, Leimenstoll, G, Paul, F & Teschemacher, HDemonstration of β-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides (1985) 6, 825–830.CrossRefGoogle ScholarPubMed
Takano, TMilk derived peptides and hypertension reduction. Int Dairy J (1998) 8CrossRefGoogle Scholar
Tome, D, Dumontier, A, Hautefeuille, M & Desjeux, JOpiate activity and transepithelial passage of intact β-casomorphins in rabbit ileum. Am J Physiology (1987) 253, G737–G744.Google ScholarPubMed
Tome, D (1998) Functional peptides. In Danone World Newsletter.Google Scholar
Turner, AJ & Hooper, NMThe angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci (2002) 23, 177–183.CrossRefGoogle ScholarPubMed
Umbach, M, Teschemacher, H, Praetorius, K, Hirschhäuser, R & Bostedt, HDemonstration of a β-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. Regul Pept (1985) 12, 223–230.CrossRefGoogle ScholarPubMed
Van der Niepen, P (2000) Niet-farmacologische Aanpak van Hypertensie, p. 10. Nefrologie-Hypertensie, Academisch Ziekenhuis, Vrije Universiteit Brussel.Google Scholar
Vanhoof, G, Goossens, F, De Meester, I, Hendriks, D & Scharpe, SProline motifs in peptides and their biological processing. FASEB J (1995) 9, 736–744.CrossRefGoogle ScholarPubMed
Vermeirssen, V, Deplancke, B, Tappenden, KA, Van Camp, J, Gaskins, HR & Verstraete, WIntestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer. J Pept Sci (2002 a) 8, 95–100.CrossRefGoogle ScholarPubMed
Vermeirssen, V, Van Camp, J, Decroos, K, Van Wijmelbeke, L & Verstraete, WThe impact of fermentation and in vitro digestion on the formation of ACE inhibitory activity from pea and whey protein. J Dairy Sci (2003 a) 86, 429–438.CrossRefGoogle ScholarPubMed
Vermeirssen, V, Van Camp, J, Devos, L & Verstraete, WRelease of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: from batch experiment to semi-continuous model. J Agric Food Chem (2003 b) 51, 5680–5687.CrossRefGoogle Scholar
Vermeirssen, V, Van Camp, J & Verstraete, WOptimisation and validation of an angiotensin converting enzyme (ACE) inhibition assay for the screening of bioactive peptides. J Biochem Biophys Methods (2002 b) 51, 75–87.CrossRefGoogle ScholarPubMed
Walker, WAAbsorption of protein and protein fragments in the developing intestine: role in immunologic/allergic reactions. Pediatrics (1985) 75, 161–171.CrossRefGoogle ScholarPubMed
Webb, KE Jr Intestinal absorption of protein hydrolysis products: a review. J Anim Sci (1990) 68, 3011–3022.CrossRefGoogle ScholarPubMed
Wilson, G, Hassan, IF, Dix, CJ, Williamson, I, Shah, R, Mackay, M & Artursson, PTransport and permeability properties of human caco-2 cells – an in vitro model of the intestinal epithelial-cell barrier. J Control Releasege (1990) 11, 25–40.CrossRefGoogle Scholar
Wu, JP & Ding, XLHypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J Agric Food Chem (2001) 49, 501–506.CrossRefGoogle ScholarPubMed
Yamamoto, NAntihypertensive peptides derived from food proteins. Biopolymers (1997) 43, 129–134.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Yamamoto, N, Ejiri, M & Mizuno, SBiogenic peptides and their potential use. Curr Pharm Des (2003) 9, 1345–1355.CrossRefGoogle ScholarPubMed
Yamamoto, N, Maeno, M & Takano, TPurification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4 J Dairy Sci (1999) 82, 1388–1393.CrossRefGoogle ScholarPubMed
Yang, CY, Dantzig, AH & Pidgeon, CIntestinal peptide transport systems and oral drug availability. Pharm Res (1999) 16, 1331–1343.CrossRefGoogle ScholarPubMed
Yigal, MP, Martin, P & Detlev, GLessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res (1998) 39, 77–88.Google Scholar
Yoshii, H, Tachi, N, Ohba, R, Sakamura, O, Takeyama, H & Itani, TAntihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks. Comp Biochem Physiol C (2001) 128, 27–33.Google ScholarPubMed
Yoshikawa, M, Fujita, H, Matoba, N, Takenaka, Y, Yamamoto, T, Yamauchi, R, Tsuruki, H & Takahata, KBioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors (2000) 12, 143–146.CrossRefGoogle ScholarPubMed
Ziv, E & Bendayan, MIntestinal absorption of peptides through the enterocytes. Microsc Res Tech (2000) 49, 346–352.3.0.CO;2-B>CrossRefGoogle ScholarPubMed